BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 26, 2017
View Archived Issues
Genocea Biosciences announces topline data from phase IIb study of GEN-003
Read More
ALT-803 induces NK- and T-cell activation in SIV-infected macaques
Read More
GlaxoSmithKline submits sNDA to the FDA for Arnuity Ellipta in children with asthma
Read More
Serum 3-nitrotyrosine is a potential prediagnosis biomarker of postsurgery sepsis
Read More
Topline data reported from Novavax's phase II study of RSV F vaccine
Read More
Phase III study of Keytruda in HNSCC misses primary endpoint
Read More
Frontier Biotechnologies enters agreement with Rockefeller University
Read More
Aptevo and Alligator Bioscience to codevelop cancer immunotherapy
Read More
Ono Pharmaceutical presents promising in vitro and preclinical data for ONO-5450598
Read More
Flex Pharma's FLX-787 wins FDA fast track status for muscle cramps in ALS patients
Read More
Investigators in China patent MAPK 1 inhibitors
Read More
Asthma compounds identified at Sichuan Haisco Pharmaceutical
Read More
Karyopharm Therapeutics presents exportin-1 antagonists
Read More
UCB files for U.S. and E.U. approvals for Cimzia in moderate to severe chronic plaque psoriasis
Read More
Compounds for cancer discovered at Karyopharm Therapeutics
Read More
Axsome Therapeutics reports positive topline results from phase I study of AXS-06
Read More
Sernova provides update on regenerative medicine therapy for hemophilia A
Read More
FDA grants fast track designation to caplacizumab for acquired thrombotic thrombocytopenic purpura
Read More
Onconova Therapeutics enters agreements to advance rigosertib in pediatric RASopathies
Read More
Tetraphase reports topline results from IGNITE4 trial of eravacycline in cIAI
Read More
AntriaBio doses first patient in phase I study of AB-101
Read More
Santen initiates phase IIa study of DE-122 for wet AMD
Read More
The Medicines Co. provides update on TANGO-2 study of meropenem/vaborbactam
Read More
Phase III data for glecaprevir/pibrentasvir combination in HIV-1/HCV coinfected patients presented
Read More
Eisai seeks approval of lenvatinib for HCC in U.S. and E.U.
Read More
